Get screened header
Icon - Arrow right

EDENT1FI screening initiatives

Local initiatives
Czech Republic Prague
Denmark Copenhagen
Sweden Lund
Germany Munich
Germany Hanover
Germany Dresden
Italy Milan
Poland Warsaw
Poland Katowice
Portugal Lisbon
United Kingdom Birmingham
Close icon
Germany HMGU Munich
Helmholtz Zentrum Muenchen
  • Principal Investigator Anette Ziegler
Czech Republic UH-MOTOL Prague
University Hospital Motol
  • Principal Investigator Zdenek Sumnik
Denmark SDCC-RH Copenhagen
Steno Diabetes Center Copenhagen - Region Hovedstaden
  • Principal Investigator Flemming Pociot
Sweden SDCC-RH Lund
Lund University Clinical Research Center Malmø
  • Principal Investigator Daniel Agardh
Germany HKA Hanover
Hannoversche Kinderheilanstalt
  • Principal Investigator Olga Kordonouri
Germany TUD Dresden
Technische Universität Dresden
  • Principal Investigator Ezio Bonifacio
Italy OSR Milan
Ospedale San Raffaele
  • Principal Investigator Emanuele Bosi
Poland MUW Warsaw
Medical University of Warsaw
  • Principal Investigator Agnieszka Szypowska
Poland SUM Katowice
Medical University of Silesia Department of Children's Diabetology
  • Principal Investigator Przemyslawa Jarosz-Chobot
Portugal APDP Lisbon
Associacao Protectora dos Diabeticos de Portugal
  • Principal Investigator João Filipe Raposo
United Kingdom UoB Birmingham
The University of Birmingham
  • Principal Investigator Parth Narendran
Icon - Arrow right

Screening initiatives outside EDENT1FI

INNODIA Navigation Tool

A digital tool by INNODIA designed to help in easily finding and connecting with clinical sites that offer screening and monitoring services. This tool will be available online by late summer 2025.

Find out more

England, Wales and Ireland

In the regions of Newcastle and Cambridge, the INGR1D2 initiative aims at identifying children with genetic markers that make them at increased risk of developing T1D.

Children aged 3-13 years in England and Wales can access home screening to detect T1D by participating in the ELSA study. Home screening is also available for adults (18-70 years) through T1DRA.

Sweden

Screening for T1D is also available in Sweden through the TRIAD study. Children between 2 and 14 years can get screened through a simple blood test taken at home. The screening will also detect celiac disease or autoimmune thyroid disease.

Denmark

If you live in Denmark, you have a close relative living with T1D and you are aged between 1 and 40, you can participate in the DiaUnion screening study. With a blood test taken at home, you will know if you have early-stage T1D, celiac disease and autoimmune thyroid disease.

Germany

Munich and Dresden offer early detection studies for newborns (up to 6 weeks of age – Freder1k) and children (2-10 years old – Fr1da).

Lisbon (Portugal)

The health team of APDP performs autoantibody screening in children (2-10 years old) to detect early-stage T1D. You can get screened at the ADPD clinic or at local sport initiatives. Check the website to get to know at which initiatives you can find the APDP team!

USA, Canada and Australia

TrialNet is a network of health care professionals and researchers working on T1D and that offers screening opportunities for family members of individuals living with T1D.

Icon - Arrow right

Clinical trials

Children, adolescents and adults with T1D can participate in clinical trials. A clinical trial is a study in which a new treatment for a specific disease is tested and its efficacy is evaluated. These studies are carefully designed and are approved before they can take place.

If you wish to participate or enroll your child in a clinical trial, or simply you are curious and want to know more about it, we invite you to contact your GP or endocrinologist, who will be able to provide you with informed advises on this matter. To search for ongoing clinical trials close to you, check these websites: Europe and UK